<!doctype html><html lang=en-us dir=ltr><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="**The Board of Appeal in the CRISPR hearing has found the Broad Institute&amp;rsquo;s patent to lack priority and dismissed the appeal (T 0844/18). **George Schlich (Opponent 1) in the CRISPR appeal has just told IPKat: &amp;ldquo;After nearly 4 days at the Board of Appeal, this was a hard fought case. We now know for absolute certain - appeal dismissed. Patent revoked.&amp;rdquo;
After yesterday&amp;rsquo;s hints from the Board of Appeal that they intended to refer the issue of priority to the Enlarged Board of Appeal, many were predicting that the Board of Appeal would go ahead with the referral (see IPKat&amp;rsquo;s report on Day 1, and Days 2-3)."><title>CRISPR hearing Day 4: Still a clear cut case of invalid priority, Broad Institute's appeal dismissed</title><link rel=canonical href=https://Nexus-Security.github.io/posts/2016-09-09-crispr-hearing-day-4-still-clear-cut/><link rel=stylesheet href=/scss/style.min.450926226e724574a6b936335ea06111f8aeb253d932c86cb2cc807341cd2889.css><meta property="og:title" content="CRISPR hearing Day 4: Still a clear cut case of invalid priority, Broad Institute's appeal dismissed"><meta property="og:description" content="**The Board of Appeal in the CRISPR hearing has found the Broad Institute&amp;rsquo;s patent to lack priority and dismissed the appeal (T 0844/18). **George Schlich (Opponent 1) in the CRISPR appeal has just told IPKat: &amp;ldquo;After nearly 4 days at the Board of Appeal, this was a hard fought case. We now know for absolute certain - appeal dismissed. Patent revoked.&amp;rdquo;
After yesterday&amp;rsquo;s hints from the Board of Appeal that they intended to refer the issue of priority to the Enlarged Board of Appeal, many were predicting that the Board of Appeal would go ahead with the referral (see IPKat&amp;rsquo;s report on Day 1, and Days 2-3)."><meta property="og:url" content="https://Nexus-Security.github.io/posts/2016-09-09-crispr-hearing-day-4-still-clear-cut/"><meta property="og:site_name" content="ZYChimne"><meta property="og:type" content="article"><meta property="article:section" content="Posts"><meta property="article:published_time" content="2020-01-16T17:57:00+01:00"><meta property="article:modified_time" content="2020-01-16T17:57:00+01:00"><meta name=twitter:title content="CRISPR hearing Day 4: Still a clear cut case of invalid priority, Broad Institute's appeal dismissed"><meta name=twitter:description content="**The Board of Appeal in the CRISPR hearing has found the Broad Institute&amp;rsquo;s patent to lack priority and dismissed the appeal (T 0844/18). **George Schlich (Opponent 1) in the CRISPR appeal has just told IPKat: &amp;ldquo;After nearly 4 days at the Board of Appeal, this was a hard fought case. We now know for absolute certain - appeal dismissed. Patent revoked.&amp;rdquo;
After yesterday&amp;rsquo;s hints from the Board of Appeal that they intended to refer the issue of priority to the Enlarged Board of Appeal, many were predicting that the Board of Appeal would go ahead with the referral (see IPKat&amp;rsquo;s report on Day 1, and Days 2-3)."></head><body class=article-page><script>(function(){const e="StackColorScheme";localStorage.getItem(e)||localStorage.setItem(e,"auto")})()</script><script>(function(){const t="StackColorScheme",e=localStorage.getItem(t),n=window.matchMedia("(prefers-color-scheme: dark)").matches===!0;e=="dark"||e==="auto"&&n?document.documentElement.dataset.scheme="dark":document.documentElement.dataset.scheme="light"})()</script><div class="container main-container flex on-phone--column extended"><aside class="sidebar left-sidebar sticky"><button class="hamburger hamburger--spin" type=button id=toggle-menu aria-label="Toggle Menu">
<span class=hamburger-box><span class=hamburger-inner></span></span></button><header><figure class=site-avatar><a href=/><img src=/img/avatar_hue825486955cd7c56d95e38b4bd2a8e3c_229979_300x0_resize_box_3.png width=300 height=300 class=site-logo loading=lazy alt=Avatar></a></figure><div class=site-meta><h1 class=site-name><a href=/>ZYChimne</a></h1><h2 class=site-description>Computer Science, Wuhan University</h2></div></header><ol class=social-menu><li><a href=https://github.com/ZYChimne target=_blank title=GitHub><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-brand-github" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z" fill="none"/><path d="M9 19c-4.3 1.4-4.3-2.5-6-3m12 5v-3.5c0-1 .1-1.4-.5-2 2.8-.3 5.5-1.4 5.5-6a4.6 4.6.0 00-1.3-3.2 4.2 4.2.0 00-.1-3.2s-1.1-.3-3.5 1.3a12.3 12.3.0 00-6.2.0C6.5 2.8 5.4 3.1 5.4 3.1a4.2 4.2.0 00-.1 3.2A4.6 4.6.0 004 9.5c0 4.6 2.7 5.7 5.5 6-.6.6-.6 1.2-.5 2V21"/></svg></a></li><li><a href=https://twitter.com/ZChimne target=_blank title=Twitter><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-brand-twitter" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z" fill="none"/><path d="M22 4.01c-1 .49-1.98.689-3 .99-1.121-1.265-2.783-1.335-4.38-.737S11.977 6.323 12 8v1c-3.245.083-6.135-1.395-8-4 0 0-4.182 7.433 4 11-1.872 1.247-3.739 2.088-6 2 3.308 1.803 6.913 2.423 10.034 1.517 3.58-1.04 6.522-3.723 7.651-7.742a13.84 13.84.0 00.497-3.753C20.18 7.773 21.692 5.25 22 4.009z"/></svg></a></li></ol><ol class=menu id=main-menu><li><a href=/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-home" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><polyline points="5 12 3 12 12 3 21 12 19 12"/><path d="M5 12v7a2 2 0 002 2h10a2 2 0 002-2v-7"/><path d="M9 21v-6a2 2 0 012-2h2a2 2 0 012 2v6"/></svg><span>Home</span></a></li><li><a href=/about-me/><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-user" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="7" r="4"/><path d="M6 21v-2a4 4 0 014-4h4a4 4 0 014 4v2"/></svg><span>About Me</span></a></li><div class=menu-bottom-section><li id=dark-mode-toggle><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-left" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="8" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-toggle-right" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="16" cy="12" r="2"/><rect x="2" y="6" width="20" height="12" rx="6"/></svg><span>Dark Mode</span></li></div></ol></aside><main class="main full-width"><article class=main-article><header class=article-header><div class=article-details><div class=article-title-wrapper><h2 class=article-title><a href=/posts/2016-09-09-crispr-hearing-day-4-still-clear-cut/>CRISPR hearing Day 4: Still a clear cut case of invalid priority, Broad Institute's appeal dismissed</a></h2></div><footer class=article-time><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-calendar-time" width="56" height="56" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><path d="M11.795 21H5a2 2 0 01-2-2V7a2 2 0 012-2h12a2 2 0 012 2v4"/><circle cx="18" cy="18" r="4"/><path d="M15 3v4"/><path d="M7 3v4"/><path d="M3 11h16"/><path d="M18 16.496V18l1 1"/></svg><time class=article-time--published>Jan 16, 2020</time></div><div><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-clock" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><polyline points="12 7 12 12 15 15"/></svg><time class=article-time--reading>3 minute read</time></div></footer></div></header><section class=article-content><p>**The Board of Appeal in the CRISPR hearing has found the Broad Institute&rsquo;s patent to lack priority and dismissed the appeal (T 0844/18). **<strong>George Schlich (Opponent 1) in the CRISPR appeal has just told IPKat: &ldquo;After nearly 4 days at the Board of Appeal, this was a hard fought case. We now know for absolute certain - appeal dismissed. Patent revoked.&rdquo;</strong></p><p>After yesterday&rsquo;s hints from the Board of Appeal that they intended to refer the issue of priority to the Enlarged Board of Appeal, many were predicting that the Board of Appeal would go ahead with the referral (see IPKat&rsquo;s report on <a class=link href=https://ipkitten.blogspot.com/2020/01/the-broad-institutes-crispr-patent.html target=_blank rel=noopener><strong>Day 1</strong></a>, and <a class=link href=https://ipkitten.blogspot.com/2020/01/crispr-hearing-days-2-3-board-of-appeal.html target=_blank rel=noopener><strong>Days 2-3</strong></a>). However, it seems that the Board of Appeal were convinced by the arguments from the opponents that the referral was not necessary. After hearing 3 days of arguments on the issue of priority, the Board felt confident that they could decide on the point of law and dismissed the appeal. The Board of Appeal <a class=link href=http://ipkitten.blogspot.com/2018/01/epo-revokes-crispr-patent-clear-cut.html target=_blank rel=noopener><strong>agreed with the opposition division</strong></a> that the priority claim was invalid.</p><p><a class=link href=https://1.bp.blogspot.com/-U-iAIgFbAAA/XiCSPwg9BJI/AAAAAAAAJz0/Ft5-IychJVA72QunlnC44Zwct6U_GWwUwCNcBGAsYHQ/s1600/end%2Bof%2Bthe%2Broad.jpg target=_blank rel=noopener><img src=https://1.bp.blogspot.com/-U-iAIgFbAAA/XiCSPwg9BJI/AAAAAAAAJz0/Ft5-IychJVA72QunlnC44Zwct6U_GWwUwCNcBGAsYHQ/s320/end%2Bof%2Bthe%2Broad.jpg loading=lazy></a></p><p><em>End of the road for EP2771468</em></p><p>The Board of Appeal (3.3.08) finished hearing submissions on priority from the parties this morning. Proceedings were then adjourned until the afternoon whilst the Board conferred. The parties undoubtedly had a tense lunch. The Board was either going to decide on the issue of priority or refer the issue to the EBA for clarification. There was a strong feeling <a class=link href=https://ipkitten.blogspot.com/2020/01/crispr-hearing-days-2-3-board-of-appeal.html target=_blank rel=noopener><strong>following the comments made by the Board of Appeal on Day 3</strong></a> that a referral to the EBA was likely. However, news came soon after recommencement of the proceedings that the Board of Appeal was to dismiss the appeal. <strong>[In a classic fake news saga, Merpel watched with bemusement today the ongoing proliferation of reports that the Board of Appeal <strong><em>had</em></strong> referred the matter to the EBA].</strong></p><p>The immediate impact of the referral would have been to prolong the dispute. Even if the EBA had accepted the referral (far from certain), any decision from the EBA would not have been the end of the matter. The EBA is there to provide clarity on points of law. After a EBA decision, the case would then have had to be sent back to the Board of Appeal. Those wishing for legal clarity will welcome the Board of Appeal&rsquo;s decision to settle the matter today.</p><p>On the other hand, a fact easily forgotten amidst the all the excitement over this week&rsquo;s appeal hearing, is that the patent in dispute, <a class=link href="https://register.epo.org/application?number=EP13818570" target=_blank rel=noopener>EP2771468</a>, is far from being the Broad Institute only patent relating to CRISPR. Whilst today is the end of the road for <a class=link href="https://register.epo.org/application?number=EP13818570" target=_blank rel=noopener>EP2771468</a>, there are 5 divisional applications in the same family as the patent in dispute: <a class=link href="https://register.epo.org/application?number=EP14170383&tab=main" target=_blank rel=noopener><strong>EP2784162</strong></a>, <a class=link href="https://register.epo.org/application?number=EP15154539&lng=en&tab=doclist" target=_blank rel=noopener><strong>EP2896697</strong></a>, <a class=link href="https://register.epo.org/application?number=EP15154565&lng=en&tab=main" target=_blank rel=noopener><strong>EP2940140</strong></a>, <a class=link href="https://register.epo.org/application?number=EP15154566&lng=en&tab=doclist" target=_blank rel=noopener><strong>EP2921557</strong></a>, <a class=link href="https://register.epo.org/application?number=EP16194919" target=_blank rel=noopener><strong>EP3144390</strong></a>.</p><p><strong><a class=link href="https://register.epo.org/application?number=EP14170383&tab=main" target=_blank rel=noopener>EP2784162</a></strong> and <a class=link href="https://register.epo.org/application?number=EP15154539&lng=en&tab=doclist" target=_blank rel=noopener><strong>EP2896697</strong></a> were revoked in opposition earlier last year. The appeals are pending. <a class=link href="https://register.epo.org/application?number=EP15154565" target=_blank rel=noopener><strong>EP2940140</strong></a>  and <a class=link href="https://register.epo.org/application?number=EP15154566&lng=en&tab=doclist" target=_blank rel=noopener><strong>EP2921557</strong></a> have been opposed. <a class=link href="https://register.epo.org/application?number=EP16194919" target=_blank rel=noopener><strong>EP3144390</strong></a> has been accepted by the Examining Division, but not yet granted. In other words, despite the dismissal of the appeal today, we may see the dispute rumble on. However, presumably, should the other cases in the family reach the Board of Appeal, with the same issues at stake, the appeals would be dealt with in the same way as the one today.</p><p>The patent family of <a class=link href="https://register.epo.org/application?number=EP13818570" target=_blank rel=noopener>EP2771468</a> is also, of course, not the only family relating to CRISPR. There are many other patents relating to aspects of CRISPR technology, owned by the Broad Institute and other parties, most notably University California Berkeley.</p><p>We now await publication of the minutes of oral proceedings and the written decision. Thanks again to all our Katfriends for their faithful reporting.</p></section><footer class=article-footer><section class=article-copyright><svg xmlns="http://www.w3.org/2000/svg" class="icon icon-tabler icon-tabler-copyright" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke="currentcolor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"/><circle cx="12" cy="12" r="9"/><path d="M14.5 9a3.5 4 0 100 6"/></svg><span>Licensed under CC BY-NC-SA 4.0</span></section></footer></article><footer class=site-footer><section class=copyright>&copy;
2020 -
2022 ZYChimne</section><section class=powerby>Built with <a href=https://gohugo.io/ target=_blank rel=noopener>Hugo</a><br>Theme <b><a href=https://github.com/CaiJimmy/hugo-theme-stack target=_blank rel=noopener data-version=3.11.0>Stack</a></b> designed by <a href=https://jimmycai.com target=_blank rel=noopener>Jimmy</a></section></footer><div class=pswp tabindex=-1 role=dialog aria-hidden=true><div class=pswp__bg></div><div class=pswp__scroll-wrap><div class=pswp__container><div class=pswp__item></div><div class=pswp__item></div><div class=pswp__item></div></div><div class="pswp__ui pswp__ui--hidden"><div class=pswp__top-bar><div class=pswp__counter></div><button class="pswp__button pswp__button--close" title="Close (Esc)"></button>
<button class="pswp__button pswp__button--share" title=Share></button>
<button class="pswp__button pswp__button--fs" title="Toggle fullscreen"></button>
<button class="pswp__button pswp__button--zoom" title="Zoom in/out"></button><div class=pswp__preloader><div class=pswp__preloader__icn><div class=pswp__preloader__cut><div class=pswp__preloader__donut></div></div></div></div></div><div class="pswp__share-modal pswp__share-modal--hidden pswp__single-tap"><div class=pswp__share-tooltip></div></div><button class="pswp__button pswp__button--arrow--left" title="Previous (arrow left)"></button>
<button class="pswp__button pswp__button--arrow--right" title="Next (arrow right)"></button><div class=pswp__caption><div class=pswp__caption__center></div></div></div></div></div><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.min.js integrity="sha256-ePwmChbbvXbsO02lbM3HoHbSHTHFAeChekF1xKJdleo=" crossorigin=anonymous defer></script><script src=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe-ui-default.min.js integrity="sha256-UKkzOn/w1mBxRmLLGrSeyB4e1xbrp4xylgAWb3M42pU=" crossorigin=anonymous defer></script><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/default-skin/default-skin.css integrity="sha256-c0uckgykQ9v5k+IqViZOZKc47Jn7KQil4/MP3ySA3F8=" crossorigin=anonymous><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/photoswipe@4.1.3/dist/photoswipe.css integrity="sha256-SBLU4vv6CA6lHsZ1XyTdhyjJxCjPif/TRkjnsyGAGnE=" crossorigin=anonymous></main></div><script src=https://cdn.jsdelivr.net/npm/node-vibrant@3.1.5/dist/vibrant.min.js integrity="sha256-5NovOZc4iwiAWTYIFiIM7DxKUXKWvpVEuMEPLzcm5/g=" crossorigin=anonymous></script><script type=text/javascript src=/ts/main.js defer></script>
<script>(function(){const e=document.createElement("link");e.href="https://fonts.googleapis.com/css2?family=Lato:wght@300;400;700&display=swap",e.type="text/css",e.rel="stylesheet",document.head.appendChild(e)})()</script></body></html>